radioimmunoassay

Radioimmunoassay (RIA) is a sophisticated laboratory technique used primarily to measure the concentration of various substances, including hormones, vitamins, drugs, antibodies, and more, within biological fluids, most commonly blood serum or plasma. Developed by Rosalyn Yalow and Solomon Berson in the 1950s, RIA revolutionized medical diagnostics and research. Yalow later received the Nobel Prize in Physiology or Medicine in 1977 for this work.

Here's how it works: The substance you want to measure (the analyte) is mixed with a known amount of its purified form, which has been labeled with a radioactive isotope. Then, antibodies specific to that analyte are added. These antibodies bind both to the unlabeled analyte in your sample and to the radiolabeled standard. The more analyte present in your original sample, the less radiolabeled substance will be bound by the antibody, and vice versa. By measuring how much radioactivity is bound to the antibodies, scientists can accurately determine the concentration of the analyte in the sample.

RIA's incredible sensitivity – it can detect substances present in parts per trillion – made it invaluable for diagnosing conditions like diabetes (measuring insulin levels), thyroid disorders, and certain cancers. It also played a crucial role in drug development and monitoring hormone therapies.

However, due to concerns about handling radioactive materials and the emergence of alternative techniques like enzyme-linked immunosorbent assay (ELISA) which don't use radioactivity, RIA is becoming less common. Nevertheless, it remains a gold standard for certain applications where its unparalleled sensitivity is essential. So while you might not hear about it in everyday conversation, radioimmunoassay represents a significant achievement in the history of medical science and continues to influence diagnostic practices today.